Ticker Scorecard - ORGO Basics Company: Organogenesis Holdings Inc. IPO Date: January 2, 2017 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $403.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.62% Avg Daily Range (30 D): $0.09 | 2.63% Avg Daily Range (90 D): $0.10 | 2.86% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .46M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 96 Avg Trade Size (Sh.) (90 D): 116 Institutional Trades Total Inst.Trades: 769 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $1.21M Avg Inst. Trade (90 D): $1.93M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.25M Avg Closing Trade (30 D): $.52M Avg Closing Trade (90 D): $.51M Avg Closing Volume: 264.42K     News Jun 6, 2024 @ 8:05 PM Organogenesis Holdings Inc. to Participate in theÃ... Source: Organogenesis Holdings Inc. May 10, 2024 @ 12:45 AM Organogenesis (ORGO) Q1 2024 Earnings Call Transcr... Source: newsfeedback@fool.com (Motley Fool Transcribing) Apr 16, 2024 @ 11:30 AM Organogenesis Holdings Inc. to Report First Quarte... Source: Organogenesis Holdings Inc. Apr 3, 2024 @ 11:30 AM Organogenesis Announces Favorable Court Ruling Dis... Source: Organogenesis Holdings Inc. Mar 1, 2024 @ 11:29 PM Why Organogenesis Holding Stock Plummeted by 18% T... Source: newsfeedback@fool.com (Eric Volkman) Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.05 $.09 $-.13 Diluted EPS $-.05 $.09 $-.13 Revenue $ 455.04M $ 115.18M $ 130.23M Gross Profit $ 342.58M $ 88.38M $ 101.04M Net Income / Loss $ -7.38M $ 12.33M $ -17.04M Operating Income / Loss $ -12.77M $ 6.24M $ -13.89M Cost of Revenue $ 112.46M $ 26.8M $ 29.2M Net Cash Flow $ -3.9M $ 4.45M $ 1.13M PE Ratio